Intended for healthcare professionals


Raloxifene can cut fracture risk

BMJ 1999; 319 doi: (Published 21 August 1999) Cite this as: BMJ 1999;319:470
  1. Scott Gottlieb
  1. New York

    Raloxifene, a drug taken to prevent osteoporosis, has been found to increase bone mineral density in the spine and hip and to reduce spinal fracture in postmenopausal women with the disease, according to a new study. Researchers studied 7705 women aged 31 to 80 to determine the effect of raloxifene treatment on the risk of vertebral and non-vertebral fractures …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription